FIGHTING HEARTBURN FOR OVER 120 YEARS!

buble-img_ZA.png

FIGHTING
HEARTBURN
FOR OVER
120 YEARS!

THE ENO STORY

ENO antacid dates back to the 19th Century, when James Crossley Eno first introduced it as a “fruit salt” to help sailors stay healthy on long journeys.

He sold it from a small pharmacy that was located in Groat Market, Newcastle. The pharmacy was situated on a seaport with a lot of sea traffic. This was a boon for sales since the sailors, by their sea travels, helped to take ENO antacid all over the world.

By 1876, demand was so great that James ENO built a factory to produce and manufacture ENO products on a larger scale.

POSITION IN THE GLOBAL MARKET

ENO antacid is now a global brand that’s marketed in many countries, including India, Brazil, South Africa, Thailand, Venezuela, and Spain.

India is considered the largest market and has recorded the maximum growth in 2013, at 18% compared to previous year. Other markets have also recorded growth over last year – Brazil (14%), South Africa (4%), and Guatemala (44%). (37)

After establishing itself in the effervescent powder market, ENO antacid has expanded into calcium carbonate based liquid and tablets. Liquid and tablet for have already been launched in India in June 2013.

ENO/GLAXO SMITH KLINE TIMELINE

1827 - James Crossley Eno is born in Newcastle, United Kingdom

1850 - James creates ENO Powder

1870 - James starts to sell the product under the name of ‘Eno Fruit Salt’

1873 - James distributes ENO by giving samples to sailors in Newcastle docks

1938 - Beecham Group Ltd. (now part of GlaxoSmithKline) acquired ENO’s Proprietaries Ltd

1989 - SmithKline US merged with The Beecham company and gave birth to SmithKline Beecham

1995 - Glaxo Smith and Wellcome merge

2000 - GlaxoSmithKline Consumer Healthcare Inc. This is when ENO came to be our brand.

 

MAJOR MARKETS

Spain, India, Brazil, South Africa, Malaysia,  Thailand,  Mexico, Asia, Australia, UK, Middle East, Africa, Pakistan, South America, Hong Kong